University of Pittsburgh Medical Center and Carnegie Mellon to create genomics engine, precision medicine tools for cancer
UPMC Enterprises said it will allocate more than $3 million over the next six months to fund the first half-dozen projects under the Pittsburgh Health Data Alliance.
Carnegie Mellon University and the University of Pittsburgh, partners in the Health Data Alliance with the University of Pittsburgh Medical Center, will use the funding to develop technologies for reducing patient falls, preventing pressure ulcers, improving the accuracy of cancer diagnoses and providing personalized treatment recommendations.
The researchers will work on the Clinical Genomics Modeling Platform engine for creating precision medicine models that can be applied to diseases and populations.
On the cancer front, the Health Data Alliance is looking to develop two technologies: a Tumor-specific Driver Identification System that delivers personalized genomic information to clinicians and Computations Pathology for Accurate Cancer Diagnosis to more effectively assess complex tumor images.
The alliance will also work on a smartphone app called MEDIvate to enable patients to update and share medication lists with providers, the PUMP solution for reducing hospital-acquired pressure ulcers, and Fall Sentinel, which the organization described as a system to enable clinical pharmacists to monitor patients in nursing homes with an eye on drug-drug interactions that could cause falls.
“This promising start bodes well for the alliance’s goal of transforming healthcare by unleashing the creativity and entrepreneurialism of leading scientists and clinicians in Pittsburgh,” UPMC Enterprises president Tal Heppenstall said in a statement.
The Pittsburgh Data Alliance was formed in March of 2015.